BiofilmX
Natural health product licensed in Canada
- Other names
- Microfilm RX
- Licence holder
- Naturo Aid Pharmaceutical Inc.
- NPN or DIN-HM
- 80078777
- Status
- Active licence
- Licence date
- 29 June 2017
- Revision date
- 31 March 2021
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- À vérifier
Serratiopeptidase is listed in the Novel Food Catalogue as a novel food not yet authorised in the European Union: in the form covered by the entry, it should not be sold until authorised. The catalogue is informative; a declaration in France is not an authorisation.
POL-NF-00692. Novel Food Catalogue (status of products under Regulation (EU) 2015/2283), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide DL-alpha-lipoïque Source : Acide DL-alpha-lipoÏque | 200 milligramme | Not calculated |
| 4-alpha-D-Glucane glucohydrolase Source : 1,4-alpha-D-Glucane glucohydrolase de Aspergillus niger (En entier) | 25 milligramme | Not calculated |
| Serratiopeptidase Source : Serrapeptase marcescens E-15 (Cellule entière) | 30,000 SPU | Not calculated |
| Protéase Source : Fungal protease from Aspergillus flavus var. oryzae (Whole) | 15,000 Unités d'hémoglobine basées sur la tyrosine, du FCC | Not calculated |
| Protéase alcaline d'Aspergillus Source : Aspergillus melleus - Entier | 4,225 Unités d'hémoglobine basées sur la tyrosine, du FCC | Not calculated |
| 1,4-bêta-D-xylane xylanohydrolase Source : Trichoderma longibrachiatum - En entier | 1,100 Unités d'activité du xylanase | Not calculated |
| (1-4)-alpha-D-galacturonan glycanohydrolase Source : Polygalacturonase de Aspergillus niger (En entier) | 50 Endo-PGU | Not calculated |
| 1,3-(1-3,1-4)-beta-D-glucan 3(4)-glucanohydrolase Source : Trichoderma longibrachiatum - En entier | 30 FCC BGU | Not calculated |
| 4-alpha-D-Glucane glucohydrolase Source : 1,4-alpha-D-Glucane glucohydrolase de Aspergillus niger (En entier) | 25 Unité de glucoamylase du FCC | Not calculated |
| 1,3-bêta-D-xylane xylanohydrolase Source : Aspergillus niger - En entier | 4,000 FCC HCU | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Aspergillus niger - En entier | 500 FCC CU | Not calculated |
| Serratiopeptidase Source : Serrapeptase marcescens E-15 (Cellule entière) | 10.3 milligramme | Not calculated |
| Protéase Source : Fungal protease from Aspergillus flavus var. oryzae (Whole) | 30 milligramme | Not calculated |
| Protéase alcaline d'Aspergillus Source : Aspergillus melleus - Entier | 21.2 milligramme | Not calculated |
| 1,4-bêta-D-xylane xylanohydrolase Source : Trichoderma longibrachiatum - En entier | 7.3 milligramme | Not calculated |
| (1-4)-alpha-D-galacturonan glycanohydrolase Source : Polygalacturonase de Aspergillus niger (En entier) | 14.25 milligramme | Not calculated |
| 1,3-(1-3,1-4)-beta-D-glucan 3(4)-glucanohydrolase Source : Trichoderma longibrachiatum - En entier | 10 milligramme | Not calculated |
| 1,3-bêta-D-xylane xylanohydrolase Source : Aspergillus niger - En entier | 10 milligramme | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Aspergillus niger - En entier | 10 milligramme | Not calculated |
Non-medicinal ingredients
Pullulane, L-Leucine, Dioxyde de silicium, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 3 days |
Uses authorised in Canada
Provides antioxidants. Helps to reduce (symptoms such as) pain, quantity of secretion, inability to perceive smell and stuffy nose from ear, nose and/or throat infections. Mucolytic enzyme that helps break down mucous.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity/allergy has been known to occur; in which case, discontinue use.
- Contre-indications
Do not use if you are pregnant or breastfeeding.
- Précautions et mises en garde
If symptoms persist or worsen, discontinue use and consult a health care practitioner. If you have a gastrointestinal lesion/ulcer, are taking anticoagulant/blood thinner or anti-inflammatory medication, or are having surgery, consult a health care practitioner prior to use. If you have diabetes, consult a health care practitioner prior to use. If you experience sweating, paleness, chills, headache, dizziness and/or confusion, discontinue use and consult a healthcare practitioner (as these may be symptoms of serious low blood sugar).
Source
Official Health Canada record, licence 80078777
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging